COPD – future prospects for women

D. H. Wilson, G. Tucker, R. J. Adams, S. Appleton, R. E. Ruffin (Adelaide, Australia)

Source: Annual Congress 2006 - COPD world-wide
Session: COPD world-wide
Session type: Thematic Poster Session
Number: 2598
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. H. Wilson, G. Tucker, R. J. Adams, S. Appleton, R. E. Ruffin (Adelaide, Australia). COPD – future prospects for women. Eur Respir J 2006; 28: Suppl. 50, 2598

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Current developments and future directions in COPD
Source: Eur Respir Rev, 29 (158) 200289; 10.1183/16000617.0289-2020
Year: 2020



The future of personalised medicine in COPD
Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Year: 2016


Challenges in COPD exacerbations and future research and unknowns
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013

Recommendations of new therapies for severe asthma and the future
Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma
Year: 2013


Is there a need for pharmacoepidemiology in asthma and COPD?
Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials
Year: 2004

What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018



Who should receive which biologic and why? Current and future approaches in severe asthma patients
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021


Attenuating future risks in children with active asthma
Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Year: 2019


Does past experience predict future exacerbations in adults with asthma?
Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD
Year: 2010

The future of COPD treatment: what are the difficulties in and barriers to drug development for COPD
Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD
Year: 2011


Planning for the future - addressing the information gaps for people living with COPD
Source: International Congress 2017 – Nursing practice across respiratory care pathways
Year: 2017


COPD - Current challenges
Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge
Year: 2008


New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012


In the era of personalized medicine, what are the current unmet needs in asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019